Table 4.
Clinical characteristics of OGI and its relationship with NLR and PLR.
| Characteristics | All patients (n = 172) | Without comorbidities (n = 87) | With comorbidities (n = 85) | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| n * | NLR | PLR | n * | NLR | PLR | n * | NLR | PLR | ||
| mean ± SD | mean ± SD | mean ± SD | mean ± SD | mean ± SD | mean ± SD | |||||
| Globe rupture | No | 91 | 4.4 ± 4.4 | 139 ± 64 | 51 | 3.7 ± 2.4 | 136 ± 53 | 40 | 5.2 ± 6.0 | 142 ± 77 |
| Yes | 81 | 7.2 ± 6.0 | 169 ± 93 | 36 | 8.5 ± 6.5 | 202 ± 101 | 45 | 6.1 ± 5.3 | 143 ± 79 | |
| P= | <0.001 | 0.015 | <0.001 | <0.001 | 0.442 | 0.959 | ||||
| Penetrating wound | No | 107 | 6.6 ± 5.6 | 159 ± 88 | 52 | 7.0 ± 6.1 | 176 ± 94 | 55 | 6.1 ± 5.0 | 143 ± 80 |
| Yes | 65 | 4.3 ± 4.9 | 144 ± 66 | 35 | 3.7 ± 2.4 | 145 ± 57 | 30 | 5.0 ± 6.7 | 142 ± 76 | |
| P= | <0.001 | 0.205 | 0.002 | 0.061 | 0.032 | 0.976 | ||||
| Intraocular foreign body | No | 149 | 5.8 ± 5.7 | 157 ± 82 | 71 | 6.1 ± 5.6 | 174 ± 86 | 78 | 5.7 ± 5.8 | 142 ± 76 |
| Yes | 23 | 4.3 ± 2.7 | 127 ± 63 | 16 | 3.8 ± 2.5 | 118 ± 36 | 7 | 5.5 ± 3.1 | 146 ± 103 | |
| P= | 0.038 | 0.047 | 0.014 | 0.005 | 0.939 | 0.904 | ||||
| Zone 1 injury | No | 74 | 7.2 ± 6.2 | 183 ± 93 | 41 | 7.8 ± 6.4 | 200 ± 95 | 33 | 6.4 ± 5.9 | 160 ± 87 |
| Yes | 75 | 3.7 ± 2.5 | 124 ± 49 | 44 | 3.7 ± 2.6 | 126 ± 44 | 31 | 3.7 ± 2.3 | 121 ± 56 | |
| P= | <0.001 | <0.001 | <0.001 | <0.001 | 0.018 | 0.039 | ||||
| Zone 2 injury | No | 113 | 5.5 ± 5.0 | 151 ± 82 | 67 | 5.7 ± 5.5 | 157 ± 85 | 46 | 5.4 ± 4.5 | 142 ± 78 |
| Yes | 36 | 5.0 ± 4.7 | 161 ± 73 | 18 | 5.6 ± 4.2 | 182 ± 70 | 18 | 4.4 ± 5.2 | 141 ± 72 | |
| P= | 0.552 | 0.481 | 0.916 | 0.220 | 0.490 | 0.953 | ||||
| Zone 3 injury | No | 111 | 4.1 ± 3.4 | 136 ± 60 | 62 | 4.2 ± 3.2 | 142 ± 58 | 49 | 4.0 ± 3.6 | 129 ± 63 |
| Yes | 38 | 9.2 ± 6.8 | 203 ± 106 | 23 | 9.5 ± 7.4 | 216 ± 110 | 15 | 8.8 ± 5.9 | 184 ± 100 | |
| P= | <0.001 | <0.001 | <0.001 | 0.001 | 0.001 | 0.023 | ||||
| Central corneal injury | No | 104 | 4.4 ± 3.1 | 139 ± 56 | 56 | 4.3 ± 2.9 | 137 ± 50 | 48 | 4.5 ± 3.2 | 142 ± 64 |
| Yes | 16 | 4.4 ± 3.1 | 123 ± 63 | 9 | 4.4 ± 3.2 | 147 ± 70 | 7 | 4.3 ± 3.1 | 95 ± 44 | |
| P= | 0.947 | 0.358 | 0.947 | 0.708 | 0.873 | 0.071 | ||||
| Paracentral corneal injury | No | 90 | 4.8 ± 3.2 | 144 ± 59 | 44 | 4.9 ± 3.1 | 149 ± 56 | 46 | 4.8 ± 3.3 | 140 ± 62 |
| Yes | 30 | 3.1 ± 2.2 | 114 ± 45 | 21 | 3.2 ± 2.1 | 114 ± 33 | 9 | 3.0 ± 2.6 | 113 ± 69 | |
| P= | 0.002 | 0.005 | 0.013 | 0.003 | 0.032 | 0.254 | ||||
| Peripheral corneal injury | No | 81 | 4.4 ± 3.2 | 133 ± 56 | 49 | 4.3 ± 3.0 | 137 ± 52 | 32 | 4.7 ± 3.6 | 126 ± 61 |
| Yes | 39 | 4.3 ± 2.9 | 146 ± 60 | 16 | 4.5 ± 2.9 | 141 ± 52 | 23 | 4.2 ± 2.9 | 149 ± 65 | |
| P= | 0.860 | 0.252 | 0.789 | 0.767 | 0.601 | 0.195 | ||||
| Total corneal injury | No | 85 | 3.9 ± 2.7 | 130 ± 57 | 46 | 3.9 ± 2.7 | 130 ± 49 | 39 | 4.0 ± 2.9 | 131 ± 65 |
| Yes | 35 | 5.6 ± 3.6 | 152 ± 56 | 19 | 5.4 ± 3.3 | 157 ± 55 | 16 | 5.8 ± 3.9 | 147 ± 58 | |
| P= | 0.015 | 0.053 | 0.054 | 0.051 | 0.053 | 0.403 | ||||
| Positive Seidel test | No | 59 | 5.0 ± 4.3 | 147 ± 70 | 36 | 4.5 ± 3.2 | 147 ± 57 | 23 | 5.8 ± 5.7 | 146 ± 88 |
| Yes | 85 | 5.6 ± 5.2 | 156 ± 88 | 43 | 6.5 ± 6.4 | 175 ± 103 | 42 | 4.8 ± 3.5 | 138 ± 66 | |
| P= | 0.408 | 0.476 | 0.077 | 0.142 | 0.458 | 0.690 | ||||
| Uveal exposure | No | 57 | 3.8 ± 2.9 | 127 ± 56 | 36 | 3.9 ± 2.5 | 137 ± 53 | 21 | 3.7 ± 3.5 | 110 ± 58 |
| Yes | 104 | 6.6 ± 6.2 | 166 ± 84 | 50 | 7.1 ± 6.2 | 182 ± 94 | 54 | 6.2 ± 6.2 | 151 ± 72 | |
| P= | <0.001 | 0.001 | 0.009 | 0.025 | 0.006 | 0.004 | ||||
| Vitreous exposureo | No | 100 | 4.5 ± 4.0 | 136 ± 60 | 55 | 4.4 ± 3.8 | 141 ± 59 | 45 | 4.6 ± 4.4 | 131 ± 60 |
| Yes | 50 | 7.4 ± 6.0 | 185 ± 95 | 28 | 8.6 ± 6.7 | 210 ± 104 | 22 | 5.8 ± 4.7 | 152 ± 72 | |
| P= | <0.001 | 0.001 | <0.001 | 0.001 | 0.285 | 0.206 | ||||
| Athalamia | No | 87 | 4.5 ± 3.4 | 145 ± 62 | 54 | 4.5 ± 3.4 | 146 ± 58 | 33 | 4.4 ±3.4 | 143 ± 68 |
| Yes | 62 | 5.5 ± 5.1 | 151 ± 94 | 24 | 6.7 ± 6.7 | 184 ± 113 | 38 | 4.8 ± 3.7 | 131 ± 73 | |
| P= | 0.163 | 0.625 | 0.059 | 0.052 | 0.671 | 0.464 | ||||
| Hyphema | No | 73 | 3.4 ± 2.3 | 130 ± 58 | 43 | 3.5 ± 2.3 | 132 ± 51 | 30 | 3.3 ± 2.3 | 128 ± 68 |
| Yes | 83 | 6.9 ± 5.7 | 165 ± 88 | 39 | 7.2 ± 6.3 | 186 ± 95 | 44 | 6.6 ± 5.3 | 146 ± 77 | |
| P= | <0.001 | 0.004 | <0.001 | 0.001 | <0.001 | 0.307 | ||||
| Anterior chamber fibrin | No | 91 | 4.8 ± 4.8 | 143 ± 80 | 53 | 5.2 ± 5.4 | 152 ± 89 | 38 | 4.3 ± 3.7 | 130 ± 65 |
| Yes | 41 | 4.9 ± 2.8 | 154 ± 50 | 20 | 4.7 ± 2.8 | 155 ± 45 | 21 | 5.1 ± 2.9 | 152 ± 56 | |
| P= | 0.066 | 0.345 | 0.601 | 0.841 | 0.029 | 0.192 | ||||
| Hypopyon | No | 128 | 4.9 ± 4.3 | 148 ± 72 | 69 | 5.2 ± 4.9 | 157 ± 80 | 59 | 4.6 ± 3.4 | 138 ± 62 |
| Yes | 6 | 3.0 ± 0.6 | 108 ± 29 | 5 | 3.1 ± 0.7 | 112 ± 31 | 1 | 2.4 | 90 | |
| P= | <0.001 | 0.019 | 0.002 | 0.029 | 0.537 | 0.444 | ||||
| Traumatic cataract | No | 53 | 4.2 ± 2.9 | 138 ± 65 | 28 | 4.9 ± 3.4 | 152 ± 68 | 25 | 3.3 ± 2.0 | 122 ± 59 |
| Yes | 61 | 4.3 ± 3.6 | 145 ± 70 | 39 | 4.3 ± 3.9 | 148 ± 75 | 22 | 4.2 ± 3.0 | 141 ± 62 | |
| P= | 0.858 | 0.539 | 0.483 | 0.813 | 0.211 | 0.283 | ||||
| Anterior capsule rupture | No | 67 | 4.2 ± 3.2 | 147 ± 73 | 36 | 4.8 ± 3.9 | 158 ± 80 | 31 | 3.6 ± 2.1 | 134 ± 63 |
| Yes | 34 | 4.2 ± 3.7 | 135 ± 59 | 23 | 4.1 ± 3.8 | 135 ± 58 | 11 | 4.4 ± 3.8 | 136 ± 63 | |
| P= | 0.952 | 0.403 | 0.514 | 0.207 | 0.414 | 0.911 | ||||
| Retinal detachment | No | 52 | 3.5 ± 2.9 | 133 ± 57 | 34 | 4.1 ± 3.4 | 147 ± 62 | 18 | 2.4 ± 1.3 | 107 ± 38 |
| Yes | 5 | 10.2 ± 6.8 | 286 ± 148 | 3 | 13.4 ± 6.4 | 332 ± 140 | 2 | 5.5 ± 5.0 | 218 ± 182 | |
| P= | 0.015 | 0.018 | 0.004 | 0.006 | 0.028 | 0.017 | ||||
OG0, Open globe injury; SVI, Severe visual impairment; NSVI, Non-SVI; SD, Standard deviation; NLR, Neutrophil-to-lymphocyte ratio; PLR, Platelet-to-lymphocyte ratio.
*
Number of patients with available data.
Bold means p < 0.05.